Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 20
Filter
1.
Aust Dent J ; 53 Suppl 1: S3-10, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18498582

ABSTRACT

As in any dental treatment procedure, a thorough patient assessment is a prerequisite for adequate treatment planning including dental implants. The literature was searched for references to patient assessment in implant treatment up to September 2007 in Medline via PubMed and an additional handsearch was performed. Patient assessment included the following aspects: (1) evaluation of patient's history, his/her complaints, desires and preferences; (2) extra-and intra-oral examination with periodontal and restorative status of the remaining dentition; (3) obligatory prerequisites were a panoramic radiograph and periapical radiographs (at least from the adjacent teeth) for diagnosis and treatment planning. Additional tomographs are required depending on the anatomic situation and the complexity of the planned restoration; (4) study casts are needed especially in more complex situations also requiring a diagnostic set-up, which can be tried-in and transferred into a provisional restoration as well as into a radiographic and surgical template. The current review clearly revealed the necessity for a thorough, structured patient assessment. Following an evaluation, a recommendation is given for implant therapy or, if not indicated, conventional treatment alternatives can be presented.


Subject(s)
Dental Implants , Patient Care Planning , Contraindications , Diagnosis, Oral , Humans , Models, Dental , Mouth Rehabilitation/methods , Radiography, Dental
2.
Dis Colon Rectum ; 44(6): 845-9, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11391146

ABSTRACT

PURPOSE: The object of this study was to evaluate technique using the ultrasonically activated scalpel as an alternative to closed hemorrhoidectomy in an unbiased evaluation of this new technology. METHODS: Thirty patients with Grade 2 or 3 symptomatic hemorrhoids were prospectively randomized to undergo closed hemorrhoidectomy assisted by electrocautery or hemorrhoidectomy with the ultrasonically activated scalpel, i.e., the Harmonic Scalpel. We evaluated the difference between techniques in operative time, postoperative pain, incontinence, and quality of life (using the Short Form-36 survey), as well as complications. RESULTS: Mean operative time for closed hemorrhoidectomy with electrocautery was 35.7 +/- 3 minutes; for Harmonic Scalpel patients, it was 31.7 +/- 2 minutes (P < 0.37). There was no statistical difference in operative time for two- or three-column hemorrhoidectomy. There was no significant difference in pain measurements reported on Day 1 (5.8 +/- 0.4 for electrocautery and 5.6 +/- 0.6 for Harmonic Scalpel, P < 0.82). On postoperative Day 7, the difference in pain between groups approached significance, with pain reported as 3.7 +/- 0.3 for electrocautery and 5.1 +/- 0.7 for Harmonic Scalpel(R) (P < 0.06). At six weeks, both groups were pain free. There was a significant decrease in pain between postoperative Days 1 and 7 in the electrocautery patients that was not seen in the Harmonic Scalpel patients. Incontinence measured preoperatively, at postoperative Day 7, and at postoperative Week 6 was similar for both groups and reflected occasional incontinence of gas. When the various items of the Short Form-36 survey were compared, there was no significant difference between posttreatment and preoperative values. There was no difference in the number of complications between patient groups. CONCLUSION: Although the Harmonic Scalpel is an effective tool in the treatment of hemorrhoidal disease, we found no specific advantage in postoperative pain, fecal incontinence, operative time, quality of life, or complications compared with traditional closed hemorrhoidectomy.


Subject(s)
Electrocoagulation/methods , Hemorrhoids/surgery , Adult , Aged , Fecal Incontinence/etiology , Female , Hemorrhoids/pathology , Humans , Male , Middle Aged , Pain, Postoperative , Prospective Studies , Surgical Instruments , Ultrasonics
3.
Am J Obstet Gynecol ; 182(6): 1427-8, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10871459

ABSTRACT

We describe 3 cases of antibiotic-induced hemolysis associated with cefotetan prophylaxis during cesarean delivery. Each of the 3 patients showed development of significant anemia with documented cefotetan-induced hemolysis. When postpartum anemia is associated with antibiotic use, immune hemolytic anemia should be considered and included in the differential diagnosis.


Subject(s)
Anemia, Hemolytic, Autoimmune/chemically induced , Antibiotic Prophylaxis/adverse effects , Cefotetan/adverse effects , Cephamycins/adverse effects , Cesarean Section , Adult , Cefotetan/therapeutic use , Cephamycins/therapeutic use , Female , Humans , Pregnancy
4.
Int J Oral Maxillofac Implants ; 14(3): 361-8, 1999.
Article in English | MEDLINE | ID: mdl-10379109

ABSTRACT

Maxillary sinus grafting procedures are currently the treatment of choice when the alveolar crest of the posterior maxilla is in close approximation to the maxillary sinus. The short-term histologic and radiographic healing following sinus grafting with natural bone mineral (Bio-Oss) in the chimpanzee has been evaluated. We have previously shown by histomorphometric and radiographic analysis that the percentage of vital bone area, the vertical height, and the density of new bone in the maxillary sinus was significantly greater with anorganic bovine bone compared to bovine Type I collagen matrix. The purpose of this in vivo study was to determine the bone mineral density (BMD) of the sinus grafts, the vertical height stability, the vital bone area, and the extent of anorganic bovine bone replacement 18 months postoperatively in 4 maxillary sinuses from 4 different animals. Radiographic analysis of computed tomographic scans taken at 1.5 years revealed an average BMD of 658 mg/mL, which was not significantly different from the values found at 6.5 months. The radiographic vertical height was maintained between the 6.5- and 18-month time points. On average, the grafts were found to have a height of 14 mm. Lateral wall biopsy specimens at 7.5 months were compared to those at 18 months. With the anorganic bovine bone treatment, the percentage of vital bone area increased from 62 +/- 3% to 70 +/- 7% and the percentage of natural bone mineral area decreased from 19 +/- 14% to 6 +/- 3%. The bovine Type I collagen matrix vital bone percentage at 7.5 months was 34 +/- 21%. These results demonstrate that sinus grafting with anorganic bovine bone maintains radiographic evidence of density and height stability of 1.5 years. In addition, histologic evidence supports the hypothesis that anorganic bovine bone is replaced by vital bone.


Subject(s)
Bone Substitutes , Bone Transplantation/methods , Maxillary Sinus/surgery , Minerals , Oral Surgical Procedures, Preprosthetic , Animals , Bone Density , Bone Regeneration , Cattle , Longitudinal Studies , Maxillary Sinus/diagnostic imaging , Pan troglodytes , Tomography, X-Ray Computed
5.
Int J Periodontics Restorative Dent ; 18(3): 227-39, 1998 Jun.
Article in English | MEDLINE | ID: mdl-9728105

ABSTRACT

Sinus grafting procedures are a viable means of ensuring adequate bone for the placement of dental implants in the posterior maxilla. In the quest to improve predictability and accelerate the time line toward receiving a final prosthesis, researchers have turned to recombinant human proteins like osteogenic protein-1 for the potential to therapeutically enhance bone formation. Bilateral sinus augmentations were performed in 15 adults chimpanzees to evaluate treatment with different doses of the osteogenic protein-1 device or natural bone mineral (Bio-Oss). Methods of evaluation included soft tissue healing, radiography (computed tomographic scan), histology, residual lateral wall defect surface area at 7.5 months, and the extent of soft tissue encleftation at 7.5 months. Findings revealed radiographic and histologic evidence of bone formation with all treatment groups and a statistically significant reduction in the depth of soft tissue encleftation and the residual lateral wall defect surface area for both the Bio-Oss and the 2.5-mg osteogenic protein-1 per gram collagen matrix treatments when compared to collagen matrix alone. These results suggest that Bio-Oss and the 2.5-mg osteogenic protein-1 per gram collagen matrix effectively stimulate bone formation in the maxillary sinus.


Subject(s)
Bone Morphogenetic Proteins , Bone Regeneration/drug effects , Bone Transplantation/methods , Maxillary Sinus/surgery , Minerals , Oral Surgical Procedures, Preprosthetic , Transforming Growth Factor beta , Analysis of Variance , Animals , Bone Morphogenetic Protein 7 , Bone Morphogenetic Proteins/pharmacology , Cattle , Collagen , Evaluation Studies as Topic , Humans , Minerals/pharmacology , Pan troglodytes , Recombinant Proteins , Wound Healing
6.
J Periodontol ; 69(8): 911-9, 1998 Aug.
Article in English | MEDLINE | ID: mdl-9736374

ABSTRACT

The posterior maxilla has traditionally been one of the most difficult areas to successfully place dental implants due to poor bone quality and close approximation to the maxillary sinus. Sinus augmentation procedures have become a viable means of assuring adequate bone for the placement of dental implants in this area. However, with the techniques currently employed, a considerable variation in the quality of bone attained with the sinus augmentation procedure exists. The purpose of this in vivo study was to evaluate the healing response and bone formation stimulated by 3 doses of recombinant human osteogenic protein-1 (rhOP-1), 0.25, 0.6, and 2.5 mg OP-1 per gram of collagen matrix; natural bone mineral; or collagen matrix alone (control) placed in the maxillary sinus of adult chimpanzees. Results were assessed using clinical, histologic, and radiographic techniques. Radiographic analysis of the computed tomography scans taken at 1 week, and 2.5, 4.5, and 6.5 months revealed a more rapid mineralization with the 2.5 mg OP-1/g collagen matrix and natural bone mineral treatment groups. The incremental bone mineral density (BMD) increase for these 2 treatments from 1 week to 2.5 months was over 2.5 times the increase found with the collagen matrix alone; these 2 treatments also had a higher BMD at the most superior slices evaluated when compared to the other 3 groups. Biopsy specimens were taken at 3.5, 5.5, and 7.5 months and for all 5 treatment groups bone formation was observed at all time points in the majority of the specimens. At 7.5 months the 2.5 and 0.6 mg OP-1/g collagen matrix treatment groups had an increase in the percent bone area when compared to the matrix alone control. In conclusion, these results demonstrate that sinus augmentation with natural bone mineral or 2.5 mg OP-1/g collagen matrix induce comparable radiographic and histologic evidence of bone formation and that both of these treatments performed superior to the control group of collagen matrix alone based upon all methods of evaluation.


Subject(s)
Bone Morphogenetic Proteins/therapeutic use , Bone Substitutes/therapeutic use , Maxillary Sinus/surgery , Minerals/therapeutic use , Transforming Growth Factor beta/therapeutic use , Analysis of Variance , Animals , Biopsy , Bone Density , Bone Matrix/transplantation , Bone Morphogenetic Protein 7 , Bone Morphogenetic Proteins/administration & dosage , Calcification, Physiologic , Collagen/therapeutic use , Dental Implantation, Endosseous , Dental Implants , Dose-Response Relationship, Drug , Evaluation Studies as Topic , Follow-Up Studies , Humans , Maxillary Sinus/diagnostic imaging , Maxillary Sinus/pathology , Maxillary Sinus/physiopathology , Osteogenesis , Pan troglodytes , Recombinant Proteins , Tomography, X-Ray Computed , Transforming Growth Factor beta/administration & dosage , Wound Healing
9.
Am J Obstet Gynecol ; 169(1): 202-4, 1993 Jul.
Article in English | MEDLINE | ID: mdl-8392792

ABSTRACT

Toxic shock syndrome can occur after any surgical procedure. We report the first case of toxic shock syndrome that has occurred after a loop electrosurgical excision procedure. The patient recovered with supportive care and antibiotics.


Subject(s)
Electrosurgery/adverse effects , Shock, Septic/etiology , Uterine Cervical Neoplasms/surgery , Adult , Ciprofloxacin/therapeutic use , Female , Humans , Papillomaviridae , Postoperative Complications , Shock, Septic/drug therapy , Shock, Septic/microbiology , Staphylococcal Infections/drug therapy , Tumor Virus Infections/surgery , Uterine Cervical Neoplasms/microbiology
10.
J Clin Gastroenterol ; 11(4): 399-402, 1989 Aug.
Article in English | MEDLINE | ID: mdl-2569489

ABSTRACT

We reviewed the course of 500 patients with Crohn's disease to document the incidence, the nature, and the results of management of fistulas to the bladder. Seventeen patients (14 men and three women) had developed enterovesical fistulas: 16 had pneumaturia. The barium radiographs demonstrated the fistula in only 37%. All had received sulfasalazine, and most were treated with corticosteroids and antibiotics intermittently; two had successful control of their urinary symptoms on this regimen. Eight patients who received 6-mercaptopurine (6-MP) in addition tolerated the urinary fistula well, so that we encourage a trial of 6-MP for this complication of Crohn's disease. Six patients continue on medical therapy alone after a mean of 5.3 years. There were no instances of pyelonephritis during 60 patient years. Eleven patients eventually underwent bowel resection, but in only two was persistence of the enterovesical fistula the primary indication for elective surgery, and in both, it was the patient's choice. Visualization of the fistula on barium enema radiograph or presence of a connection between the sigmoid and the bladder were not associated with adverse outcome. An enterovesical fistula in Crohn's disease rarely leads to serious complications and can often be treated successfully with medical therapy alone: by itself, it need not serve as an indication for surgery.


Subject(s)
Crohn Disease/complications , Intestinal Fistula/drug therapy , Urinary Bladder Fistula/drug therapy , Adult , Analgesics/therapeutic use , Anti-Bacterial Agents/therapeutic use , Female , Humans , Intestinal Fistula/etiology , Male , Mercaptopurine/therapeutic use , Sulfasalazine/therapeutic use , Urinary Bladder Fistula/etiology
16.
West J Med ; 133(4): 289-91, 1980 Oct.
Article in English | MEDLINE | ID: mdl-7347043

ABSTRACT

Recently, there has been increased interest in the influence of maternal prenatal nutrition on the course and outcome of pregnancy. Evidence has accumulated that a woman's weight before pregnancy and the weight gained during pregnancy directly affect infant birth weight, incidence of neonatal mortality, and growth and development of the infant during the first year of life. Although recent recommendations for weight gain in pregnancy have been liberalized, a survey of 195 pregnant women who had prenatal visits in both clinic and private offices showed deficiencies in their understanding of the subject. Some 37 percent of women believed they should gain 20 pounds (9 kg) or less during pregnancy. Eight percent admitted to dieting before at least one antenatal visit and 54 percent thought their doctor would not be concerned about too little weight gained during pregnancy. This suggests that many women and some doctors are still ignorant of current concepts of proper nutrition during pregnancy. Apparently, increased lay and professional educational efforts are needed.


Subject(s)
Attitude to Health , Body Weight , Pregnancy , Prenatal Care/psychology , Female , Humans
SELECTION OF CITATIONS
SEARCH DETAIL
...